Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 65.18%-38.7K | 178.14%19.66K | 100.40%456 | 53.73%-354.43K | 51.12%-102.68K | 18.43%-111.15K | 84.65%-25.15K | 54.85%-115.44K | 64.39%-765.93K | 36.98%-210.07K |
| Net income from continuing operations | -197.59%-102.76K | 45.04%-116.54K | 64.14%-66.77K | 78.16%-260.48K | 163.32%172.27K | 72.51%-34.53K | 41.28%-212.06K | 57.07%-186.16K | 60.06%-1.19M | 48.95%-272.06K |
| Operating gains losses | -114.80%-3.48K | -66.16%5.92K | -4,252.01%-66.02K | -430.62%-43.24K | -909.71%-82.71K | 877.79%23.5K | 964.98%17.49K | -106.70%-1.52K | -73.48%13.08K | -196.41%-8.19K |
| Depreciation and amortization | --0 | --0 | 0.00%2.23K | -41.11%8.92K | 223,100.00%2.23K | 0.00%2.23K | -72.64%2.23K | -53.23%2.23K | -65.76%15.15K | -100.01%-1 |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -98.64%7.5K | --0 |
| Other non cashItems | 124.08%19.24K | -78.97%18.09K | -77.14%17.6K | -166.18%-106.81K | -217.75%-189.93K | ---79.91K | --86.03K | 88,406.90%77K | 11,757.97%161.39K | --161.3K |
| Change In working capital | 315.27%48.29K | 38.23%112.19K | 1,720.56%113.41K | -79.43%47.18K | 95.01%-4.54K | -127.64%-22.43K | -56.70%81.16K | -104.89%-7K | 23.29%229.41K | -214.27%-91.12K |
| -Change in prepaid assets | ---- | --0 | --0 | --0 | --0 | -219.18%-20.95K | 239.11%41.9K | -87.76%-20.95K | -101.48%-2.17K | -152.39%-20.95K |
| -Change in payables and accrued expense | 3,354.25%48.29K | 185.77%112.19K | 712.84%113.41K | -79.63%47.18K | 93.53%-4.54K | 94.59%-1.48K | -77.57%39.26K | -90.95%13.95K | 494.92%231.58K | -276.51%-70.17K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 65.18%-38.7K | 178.14%19.66K | 100.40%456 | 53.73%-354.43K | 51.12%-102.68K | 18.43%-111.15K | 84.65%-25.15K | 54.85%-115.44K | 64.39%-765.93K | 36.98%-210.07K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 28.29%65.02K | -99.52%375 | 0 | -60.36%302.25K | -20.65%84.74K | -77.84%50.68K | -50.80%77.57K | -66.86%89.27K | 2,079.36%762.45K | 1,371.88%106.79K |
| Net issuance payments of debt | 16.54%65.02K | -99.52%375 | --0 | -59.69%307.36K | -20.65%84.74K | -75.60%55.79K | -50.80%77.57K | -66.86%89.27K | 2,079.36%762.45K | 1,371.88%106.79K |
| Net other financing activities | ---- | ---- | ---- | ---5.11K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 28.29%65.02K | -99.52%375 | --0 | -60.36%302.25K | -20.65%84.74K | -77.84%50.68K | -50.80%77.57K | -66.86%89.27K | 2,079.36%762.45K | 1,371.88%106.79K |
| Net cash flow | ||||||||||
| Beginning cash position | -99.17%275 | -99.68%148 | -99.39%147 | -7.23%24.27K | -92.16%10.12K | -45.47%33.23K | 229.19%46.54K | -7.23%24.27K | -98.85%26.16K | -68.15%129.01K |
| Current changes in cash | 143.52%26.32K | 154.58%20.03K | -97.52%456 | -1,401.47%-52.18K | 82.63%-17.94K | -165.44%-60.47K | 226.01%7.87K | 34.60%18.37K | 99.84%-3.48K | 69.78%-103.28K |
| Effect of exchange rate changes | -72.77%10.17K | 6.02%-19.9K | -111.66%-455 | 1,671.34%28.06K | 642.45%7.97K | 253.60%37.36K | -139.93%-21.18K | 115.21%3.9K | 102.73%1.58K | 96.05%-1.47K |
| End cash Position | 263.40%36.77K | -99.17%275 | -99.68%148 | -99.39%147 | -99.39%147 | -92.16%10.12K | -45.47%33.23K | 229.19%46.54K | -7.23%24.27K | -7.23%24.27K |
| Free cash from | 65.18%-38.7K | 178.14%19.66K | 100.40%456 | 53.73%-354.43K | 51.12%-102.68K | 18.43%-111.15K | 84.65%-25.15K | 54.85%-115.44K | 64.39%-765.93K | 36.98%-210.07K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.